Group 1 pediatric patients with COVID-19 who recovered without sequelae exhibited the lowest ADCP activity and had the lowest serum concentrations of IL-6 and TNF, cytokines associated with ARDS, and poor outcome in clinical studies (16). This evidence concerns the gene TNF and COVID-19.